Gerresheimer AG (ETR:GXI) Receives €73.20 Consensus Price Target from Analysts

Shares of Gerresheimer AG (ETR:GXI) have been assigned a consensus recommendation of “Hold” from the twelve ratings firms that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is €73.20 ($85.12).

Several equities analysts have commented on the stock. Goldman Sachs Group set a €65.00 ($75.58) target price on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Thursday, July 11th. HSBC set a €85.00 ($98.84) price target on shares of Gerresheimer and gave the company a “buy” rating in a research report on Wednesday, September 11th. Hauck & Aufhaeuser set a €50.00 ($58.14) price target on shares of Gerresheimer and gave the company a “sell” rating in a research report on Friday, July 12th. Deutsche Bank set a €83.00 ($96.51) price target on shares of Gerresheimer and gave the company a “buy” rating in a research report on Friday, July 12th. Finally, Independent Research set a €80.00 ($93.02) price target on shares of Gerresheimer and gave the company a “neutral” rating in a research report on Monday, July 15th.

Shares of GXI traded down €1.95 ($2.27) during mid-day trading on Friday, hitting €67.55 ($78.55). The stock had a trading volume of 94,435 shares, compared to its average volume of 140,925. Gerresheimer has a 52 week low of €51.10 ($59.42) and a 52 week high of €77.55 ($90.17). The company has a debt-to-equity ratio of 64.56, a current ratio of 0.85 and a quick ratio of 0.56. The firm has a market cap of $2.12 billion and a P/E ratio of 10.25. The business has a fifty day moving average price of €68.03 and a 200-day moving average price of €67.67.



Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Recommended Story: Stop Order

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.